Jupiter Life Line Hospitals Limited has filed its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The healthcare company submitted the mandatory documentation to both the National Stock Exchange of India and BSE Limited on April 3, 2026.

Regulatory Compliance Filing

The certificate was submitted in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Suma Upparatti signed the submission letter, forwarding the certificate received from the company's Registrar and Share Transfer Agent.

Share Transfer Agent Certification

KFin Technologies Limited, serving as the Registrar and Share Transfer Agent, issued the compliance certificate on April 3, 2026. Vice President Dnyanesh Gharote signed the certification document, confirming that all required details regarding securities dematerialization and rematerialization have been furnished to the stock exchanges.

Dematerialization Status

The certificate confirms a significant operational milestone for the company's securities management:

• The entire holding of Jupiter Life Line Hospitals Limited remains in demat form for the quarter ended March 31, 2026
• No rematerialization requests were received during the reporting period
• Complete digitization of shareholding maintained throughout the quarter

Stakeholder Communication

The compliance certificate was distributed to key market infrastructure institutions. KFin Technologies Limited copied the National Securities Depository Limited and Central Depository Services (India) Limited on the certification, ensuring comprehensive regulatory communication across the depository ecosystem.

The filing demonstrates the company's adherence to SEBI's regulatory framework for depositories and participants, maintaining transparency in its securities handling processes. The complete dematerialization status reflects the company's alignment with digital securities management practices in the Indian capital markets.

Jupiter Life Line Hospitals has officially received acceptance from the Mumbai Metropolitan Region Development Authority (MMRDA) for its tender regarding land allotment on a lease basis. The company announced this significant development through a regulatory filing, marking a major milestone in its expansion strategy.

Land Lease Agreement Details

The MMRDA has approved an 80-year land lease for Jupiter Life Line Hospitals, representing a substantial commitment for healthcare infrastructure development in the Mumbai metropolitan region.

Project Specifications

The allotted land is situated at plot number SF5 in the GTxT-Block of Bandra-Kurla Complex, Maharashtra. The company plans to develop a 400-bed hospital facility on this substantial land parcel, subject to various statutory and regulatory approvals.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has confirmed that the execution of the project will be undertaken in a phased manner within timelines stipulated in definitive agreements and project implementation plans.

The capital expenditure for the proposed project will be determined based on detailed project plans, funding arrangements, and approvals, with considerations by the Board of Directors from time to time. The company has clarified that this transaction does not fall within the ambit of related party transactions and that promoters have no interest in MMRDA.

Strategic Impact

This land lease approval provides Jupiter Life Line Hospitals with a strategic foothold in the prime Bandra-Kurla Complex area. The 80-year lease term offers long-term operational security and positions the company for significant expansion in Mumbai's healthcare sector. The substantial land area creates comprehensive opportunities for medical services expansion and infrastructure development aligned with the company's growth objectives.